Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 466 AL 480

An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer's disease: targeting molecular approach Nrf2, NF-κB, and CREB

Bhardwaj S, Grewal AK, Singh S, Dhankar V, Jindal A.

Inflammopharmacology. 2024 Oct;32(5):2943-2960. doi: 10.1007/s10787-024-01502-2. Epub 2024 Jun 29.

APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets

Sirisi S, Sánchez-Aced É, Belbin O, Lleó A.

Alzheimers Res Ther. 2024 Jun 29;16(1):144. doi: 10.1186/s13195-024-01504-w.

Calcium (Ca(2+)) hemostasis, mitochondria, autophagy, and mitophagy contribute to Alzheimer's disease as early moderators

Hadi F, Mortaja M, Hadi Z.

Cell Biochem Funct. 2024 Jul;42(5):e4085. doi: 10.1002/cbf.4085.

[Research Advances in the Association Between Alzheimer's Disease and Double-Stranded RNA-Dependent Protein Kinase]

Gong Y, Xiao XY, Hu YS, Xie YW, Wu ZH.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Jun;46(3):425-434. doi: 10.3881/j.issn.1000-503X.15792.

Neolignans in Magnolia officinalis as natural anti-Alzheimer's disease agents: A systematic review

Li N, Liang Y, Zhang L, Xu C, Wang L.

Ageing Res Rev. 2024 Aug;99:102398. doi: 10.1016/j.arr.2024.102398. Epub 2024 Jun 30.

Evidence mapping and quality assessment of systematic reviews on exercise intervention for Alzheimer's disease

Xu Z, Tang J, Yi W.

Complement Ther Med. 2024 Sep;84:103065. doi: 10.1016/j.ctim.2024.103065. Epub 2024 Jun 30.

Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer's Disease

Faraji P, Kühn H, Ahmadian S.

J Mol Neurosci. 2024 Jul 3;74(3):62. doi: 10.1007/s12031-024-02224-4.

Comparison of the effect of online physical exercise and computerized cognitive stimulation in patients with Alzheimer's disease during the Covid-19 pandemic

Akbuga Koc E, Yazici-Mutlu Ç, Cinar N, Sahiner T.

Complement Ther Clin Pract. 2024 Nov;57:101881. doi: 10.1016/j.ctcp.2024.101881. Epub 2024 Jul 1.

Exploring the therapeutic potential of steroidal alkaloids in managing Alzheimer's disease

Pandey PP, Kumar MS.

Steroids. 2024 Sep;209:109468. doi: 10.1016/j.steroids.2024.109468. Epub 2024 Jul 2.

Amyloid-β as a Key Player in Cerebrovascular Dysfunction in Alzheimer's Disease

Stelzer GT, Lima-Filho RAS.

J Neurosci. 2024 Jul 3;44(27):e0663242024. doi: 10.1523/JNEUROSCI.0663-24.2024.

Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer's disease: Multimodal Preventive Trial for Alzheimer's Disease (MIND-AD(mini))

Levak N, Lehtisalo J, Thunborg C, Westman E, Andersen P, Andrieu S, Broersen LM, Coley N, Hartmann T, Irving GF, Mangialasche F, Ngandu T, Pantel J, Rosenberg A, Sindi S, Soininen H, Solomon A, Wang R, Kivipelto M.

Alzheimers Res Ther. 2024 Jul 3;16(1):147. doi: 10.1186/s13195-024-01522-8.

Effect of gamification with a support partner to increase physical activity in older adults at risk for Alzheimer's disease: The STEP 4Life randomized clinical trial

Greysen SR, Oon AL, Harkins K, Rareshide C, Mondal A, Patel MS, Grill JD, Karlawish J.

Alzheimers Dement. 2024 Aug;20(8):5450-5459. doi: 10.1002/alz.14058. Epub 2024 Jul 4.

A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model

Pluta R.

Curr Alzheimer Res. 2024;21(3):166-182. doi: 10.2174/0115672050320921240627050736.

The heterogeneity of Alzheimer's disease

Husain M.

Brain. 2024 Jul 5;147(7):2259-2260. doi: 10.1093/brain/awae182.

Early-onset Alzheimer dementia superimposed on schizophrenia: a rare case report

Boylu ME, Uyar E.

Neurocase. 2024 Aug;30(3):116-120. doi: 10.1080/13554794.2024.2374544. Epub 2024 Jul 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias